In this context, it was reported that the proportion of tumor-infiltrating CD8+ CTLs was diminished during tumor growth [53], exhibiting a shift of the immune profile within the tumor microenvironment from Th1 to Th2. This evidence concerns the gene CD8A and neoplasm.